Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
22 विचारों
administrator
07/30/23
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली